JY
CODX

Jeff Yass’s Co-Diagnostics CODX Stock Holding History

Jeff Yass’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-390
Closed -$14.6K – 12316
2024
Q3 		$14.6K Buy
+390
New +$15K ﹤0.01% 11678
2023
Q2 		– Sell
-1,187
Closed -$52.7K – 12189
2023
Q1 		$52.7K Buy
1,187
+137
+13% +$11K ﹤0.01% 11680
2022
Q4 		$79.4K Sell
1,050
-4,667
-82% -$437K ﹤0.01% 11128
2022
Q3 		$551K Sell
5,717
-8,010
-58% -$1.12M ﹤0.01% 8225
2022
Q2 		$2.31M Buy
13,727
+4,704
+52% +$715K ﹤0.01% 4614
2022
Q1 		$1.67M Buy
9,023
+5,173
+134% +$1.07M ﹤0.01% 5873
2021
Q4 		$1.03M Sell
3,850
-983
-20% -$258K ﹤0.01% 7214
2021
Q3 		$1.41M Buy
4,833
+2,356
+95% +$688K ﹤0.01% 6650
2021
Q2 		$613K Sell
2,477
-290
-10% -$74.5K ﹤0.01% 9086
2021
Q1 		$792K Sell
2,767
-7,480
-73% -$2.99M ﹤0.01% 8333
2020
Q4 		$2.86M Buy
10,247
+3,314
+48% +$1.23M ﹤0.01% 4385
2020
Q3 		$2.83M Sell
6,933
-9,180
-57% -$4.72M ﹤0.01% 3974
2020
Q2 		$9.35M Buy
16,113
+11,760
+270% +$5.37M ﹤0.01% 2211
2020
Q1 		$995K Buy
+4,353
New +$755K ﹤0.01% 5416

Other funds holding CODX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAG
Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's CODX Position: Q2 2026 in Review

Jeff Yass opened a new position in Co-Diagnostics (CODX) in Q2 2026: 31,239 shares worth $96.8K. The stake represents ﹤0.01% of the portfolio and ranks #12518 among its holdings. This is a return to the name: Jeff Yass previously reported a position in CODX as recently as Q4 2025.

Jeff Yass first reported a position in CODX in Q1 2020 and has held it in 25 quarters since. The position peaked at $4.13M in Q3 2021. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

  • Jeff Yass held 31,239 shares of Co-Diagnostics worth $96.8K as of Q2 2026.
  • Co-Diagnostics was a new Jeff Yass position in Q2 2026.
  • Co-Diagnostics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12518 holding.
  • Jeff Yass first reported a position in Co-Diagnostics in Q1 2020 and has held it in 25 quarters since.
  • Jeff Yass's Co-Diagnostics position peaked at $4.13M in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.